rs17846933
Positions:
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 0P and 11B. BP4_StrongBP6_ModerateBP7BS2
The NM_001127222.2(CACNA1A):āc.5988G>Cā(p.Thr1996Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000442 in 1,356,678 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Genomes: not found (cov: 32)
Exomes š: 0.0000044 ( 0 hom. )
Consequence
CACNA1A
NM_001127222.2 synonymous
NM_001127222.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -3.78
Genes affected
CACNA1A (HGNC:1388): (calcium voltage-gated channel subunit alpha1 A) Voltage-dependent calcium channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, and gene expression. Calcium channels are multisubunit complexes composed of alpha-1, beta, alpha-2/delta, and gamma subunits. The channel activity is directed by the pore-forming alpha-1 subunit, whereas, the others act as auxiliary subunits regulating this activity. The distinctive properties of the calcium channel types are related primarily to the expression of a variety of alpha-1 isoforms, alpha-1A, B, C, D, E, and S. This gene encodes the alpha-1A subunit, which is predominantly expressed in neuronal tissue. Mutations in this gene are associated with 2 neurologic disorders, familial hemiplegic migraine and episodic ataxia 2. This gene also exhibits polymorphic variation due to (CAG)n-repeats. Multiple transcript variants encoding different isoforms have been found for this gene. In one set of transcript variants, the (CAG)n-repeats occur in the 3' UTR, and are not associated with any disease. But in another set of variants, an insertion extends the coding region to include the (CAG)n-repeats which encode a polyglutamine tract. Expansion of the (CAG)n-repeats from the normal 4-18 to 21-33 in the coding region is associated with spinocerebellar ataxia 6. [provided by RefSeq, Jul 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -11 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.65).
BP6
Variant 19-13212693-C-G is Benign according to our data. Variant chr19-13212693-C-G is described in ClinVar as [Likely_benign]. Clinvar id is 2948207.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-3.78 with no splicing effect.
BS2
High AC in GnomAdExome4 at 6 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CACNA1A | NM_001127222.2 | c.5988G>C | p.Thr1996Thr | synonymous_variant | 41/47 | ENST00000360228.11 | NP_001120694.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1A | ENST00000360228.11 | c.5988G>C | p.Thr1996Thr | synonymous_variant | 41/47 | 1 | NM_001127222.2 | ENSP00000353362.5 | ||
CACNA1A | ENST00000638029.1 | c.6006G>C | p.Thr2002Thr | synonymous_variant | 42/48 | 5 | ENSP00000489829.1 | |||
CACNA1A | ENST00000573710.7 | c.5994G>C | p.Thr1998Thr | synonymous_variant | 41/47 | 5 | ENSP00000460092.3 | |||
CACNA1A | ENST00000635727.1 | c.5991G>C | p.Thr1997Thr | synonymous_variant | 41/47 | 5 | ENSP00000490001.1 | |||
CACNA1A | ENST00000637769.1 | c.5991G>C | p.Thr1997Thr | synonymous_variant | 41/47 | 1 | ENSP00000489778.1 | |||
CACNA1A | ENST00000636012.1 | c.5991G>C | p.Thr1997Thr | synonymous_variant | 41/46 | 5 | ENSP00000490223.1 | |||
CACNA1A | ENST00000637736.1 | c.5850G>C | p.Thr1950Thr | synonymous_variant | 40/46 | 5 | ENSP00000489861.1 | |||
CACNA1A | ENST00000636389.1 | c.5991G>C | p.Thr1997Thr | synonymous_variant | 41/47 | 5 | ENSP00000489992.1 | |||
CACNA1A | ENST00000637432.1 | c.6006G>C | p.Thr2002Thr | synonymous_variant | 42/48 | 5 | ENSP00000490617.1 | |||
CACNA1A | ENST00000636549.1 | c.5997G>C | p.Thr1999Thr | synonymous_variant | 42/48 | 5 | ENSP00000490578.1 | |||
CACNA1A | ENST00000637927.1 | c.5994G>C | p.Thr1998Thr | synonymous_variant | 41/47 | 5 | ENSP00000489715.1 | |||
CACNA1A | ENST00000635895.1 | c.5991G>C | p.Thr1997Thr | synonymous_variant | 41/47 | 5 | ENSP00000490323.1 | |||
CACNA1A | ENST00000638009.2 | c.5991G>C | p.Thr1997Thr | synonymous_variant | 41/47 | 1 | ENSP00000489913.1 | |||
CACNA1A | ENST00000637276.1 | c.5991G>C | p.Thr1997Thr | synonymous_variant | 41/46 | 5 | ENSP00000489777.1 | |||
CACNA1A | ENST00000636768.1 | n.*290G>C | non_coding_transcript_exon_variant | 6/10 | 5 | ENSP00000490190.2 | ||||
CACNA1A | ENST00000636768.1 | n.*290G>C | 3_prime_UTR_variant | 6/10 | 5 | ENSP00000490190.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD3 exomes AF: 0.00000616 AC: 1AN: 162232Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 85752
GnomAD3 exomes
AF:
AC:
1
AN:
162232
Hom.:
AF XY:
AC XY:
0
AN XY:
85752
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000442 AC: 6AN: 1356678Hom.: 0 Cov.: 33 AF XY: 0.00000302 AC XY: 2AN XY: 663322
GnomAD4 exome
AF:
AC:
6
AN:
1356678
Hom.:
Cov.:
33
AF XY:
AC XY:
2
AN XY:
663322
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Episodic ataxia type 2;C4310716:Developmental and epileptic encephalopathy, 42 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 25, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at